Representative Work Representative Work

Genesys Capital in Enspire DBS Therapy’s $10.3-million Series B1 financing

On January 13, 2026,  Enspire DBS Therapy, Inc. announced that it raised $10.3 million in a Series B1 financing led by Genesys Capital. It also saw participation from existing investors Cleveland Clinic and JobsOhio Ventures. Genesys Capital invests in and builds companies in the...

Lead Office: Toronto Date Announced: January 13, 2026 Value: $10.3 million

Impression Ventures in 401GO’s $33-million Series B financing

On December 9, 2025, 401GO announced it raised $33 million of Series B Financing in a round that was led by Centana Growth Partners and had participation from Impression Ventures, Next Frontier Capital and Rally Ventures. Impression Ventures is a Toronto-based venture capital firm that invests...

Lead Office: Toronto Date Announced: December 9, 2025 Value: $33 million

Pattern Energy in its agreement to acquire Cordelio Power

On January 6, 2026, Pattern Energy Group announced it had entered into a definitive agreement to acquire Cordelio Power, an independent power producer in Canada and the United States. The addition of Cordelio Power will allow Pattern Energy to expand into one of the largest independent clean...

Lead Office: Toronto Date Announced: January 6, 2026 Value: --

2Story US Group, Inc. in the sale of its minority interest in Naturpark

On December 22, 2025, Osler acted for 2Story US Group, Inc. in the sale of its minority interest in Naturpak (formerly IPM Foods). Naturpak is the largest Tetra Recart manufacturing and co-packing company in North America and a leading full-service co-manufacturer and co-packer of shelf-stable...

Lead Office: Vancouver Date Announced: December 22, 2025 Value: --

Continuim partners with MindCore Technologies

In December 2025, Continuim Equity Partners announced its partnership with MindCore Technologies, Inc. The acquisition represents Continuim’s third platform investment within Continuim Equity Partners Fund II, along with its second investment within its Power Generation, Transmission, and...

Lead Office: Montreal Date Announced: December 17, 2025 Value: --

Albemarle Corporation in connection with its acquisition of offtake rights from Winsome Resources

On December 14, 2025, Albemarle Corporation announced its acquisition from Winsome Resources of offtake rights to lithium, cesium and tantalum from Power Metals Corp.’s Case Lake development project in eastern Ontario. Albemarle and Power Metals further agreed to amend and restate the terms...

Lead Office: Toronto Date Announced: December 14, 2025 Value: --

Medici Technologies Inc. (dba Livewell) in its sale to Hims & Hers

On December 4, 2025, Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, announced its expansion into Canada through its acquisition of Medici Technologies Inc. (dba Livewell). Livewell is a trusted Canadian digital health platform focused...

Lead Office: Montreal Date Announced: December 4, 2025 Value: --

Laurentian Bank in its sale of its retail and SME banking portfolios to National Bank of Canada and acquisition by Fairstone Bank

On December 2, 2025, Laurentian Bank of Canada (Laurentian Bank) announced that it entered into a definitive agreement to sell its retail and SME banking portfolios (the Retail/SME Transaction) to National Bank of Canada (National Bank) and a separate definitive agreement pursuant to which...

Lead Office: -- Date Announced: December 2, 2025 Value: $1.9 billion

Scotiabank in its agreement to transfer banking operations in Colombia, Costa Rica and Panama

On December 1, 2025, Scotiabank and Davivienda announced the closing of the previously announced transaction to transfer Scotiabank’s banking operations in Colombia, Costa Rica, and Panama to Davivienda. The combined operations of both institutions will operate under a new holding company,...

Lead Office: Toronto Date Announced: December 1, 2025 Value: approximately $1 billion

Morphocell Technologies Inc. in its completion of US$50-million Series A

On December 2, 2025, Morphocell Technologies Inc. announced it completed US$50-million Series A financing following a US$10-million add-on led by Investissement Québec. Morphocell Technologies Inc. is a biotechnology company. Osler, Hoskin & Harcourt LLP advised Morphocell Technologies...

Lead Office: Montreal Date Announced: December 2, 2025 Value: US$50 million